Impact of the Updated Guidance for Palivizumab Prophylaxis against Respiratory Syncytial Virus Infection: A Single Center Experience-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of the Updated Guidance for Palivizumab Prophylaxis against Respiratory Syncytial Virus Infection: A Single Center Experience

Published:2017-02 Issue: Volume:181 Page:183-188.e1
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Rajah Bavani,Sánchez Pablo J.,Garcia-Maurino Cristina,Leber Amy,Ramilo Octavio,Mejias Asuncion

Funder

Research Institute at Nationwide Children's Hospital

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology, and Child Health

Reference27 articles.

1. Risk factors in children hospitalized with RSV bronchiolitis versus non-RSV bronchiolitis;Garcia;Pediatrics,2010

2. The changing landscape of respiratory syncytial virus;Polack;Vaccine,2015

3. The burden of respiratory syncytial virus infection in young children;Hall;N Engl J Med,2009

4. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group;Pediatrics,1998

5. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease;Feltes;J Pediatr,2003

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palivizumab Prophylaxis in Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection;Pediatrics;2023-06-26

2. Current strategies and perspectives for active and passive immunization against Respiratory Syncytial Virus in childhood;Jornal de Pediatria;2023-03

3. RSV-related hospitalization and outpatient palivizumab use in very preterm (born at <29 wGA) infants: 2003-2020;Human Vaccines & Immunotherapeutics;2022-11-22

4. Real-World Studies of Respiratory Syncytial Virus Hospitalizations among Moderate/Late Preterm Infants Exposed to Passive Immunoprophylaxis with Palivizumab;American Journal of Perinatology;2022-10-28

5. Mortality Among US Infants and Children Under 5 Years of Age with Respiratory Syncytial Virus and Bronchiolitis: A Systematic Literature Review;The Journal of Infectious Diseases;2022-08-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3